36 Stocks Moving In Friday's Mid-Day Session

Gainers

• Forge Global Holdings, Inc. FRGE shares jumped 66.4% to $20.70.
• Clever Leaves Holdings Inc. CLVR jumped 29.1% to $2.04 after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.
• Joby Aviation, Inc. JOBY shares gained 20.5% to $6.43 following better-than-expected Q4 results.
• Agrify Corporation AGFY surged 18.4% to $4.74. Agrify recently reported worse-than-expected Q4 results and issued FY22 sales guidance below estimates.
• cbdMD, Inc. YCBD rose 18.4% to $1.2902 after jumping 31% on Thursday.
• Greenlane Holdings, Inc. GNLN shares rose 15.1% to $0.6972. Greenlane is expected to host Q4 conference call on March 31, 2022.
• Höegh LNG Partners LP HMLP gained 15% to $6.32. The company released Q4 results last month.
• QualTek Services Inc. QTEK surged 12.6% to $3.74.
• RADA Electronic Industries Ltd. RADA gained 12% to $16.00. Alliance Global Partners recently downgraded Rada Electronics from Buy to Neutral.
• India Globalization Capital, Inc. IGC shares rose 11.6% to $1.06 after jumping 10% on Thursday.
• Cutera, Inc. CUTR surged 10.5% to $50.43 after the company announced it received FDA 510(k) clearance of AviClear, a designation for the treatment of mild, moderate, and severe acne.
• Corbus Pharmaceuticals Holdings, Inc. CRBP rose 10.4% to $0.5534 after gaining 5% on Thursday.
• SciSparc Ltd. SPRC shares gained 9.6% to $4.8799 following an afternoon report Thursday US House Rules Committee has scheduled a Monday-afternoon meeting to prep federal marijuana legalization bill for floor action.
• Tilray Brands, Inc. TLRY rose 9.6% to $7.64 after surging around 22% on Thursday.
• CONSOL Energy Inc. CEIX gained 8.2% to $40.21.

Losers

• MEI Pharma, Inc. MEIP shares fell 57.7% to $0.7650 after the company provided an update on its PI3K inhibitor drug candidate zandelisib following a meeting with the FDA. The company does not plan to submit an FDA marketing application based on the single arm Phase 2 TIDAL study, following discouragement from the agency. Several analysts also downgraded the stock.
• Icosavax, Inc. ICVX shares dipped 51.8% to $6.00 after the company reported the results from its Phase 1/2 trial for IVX-441 against SARS-CoV-2 showed the level of response was lower than expected and inconsistent with known data on the company's platform and VLP technology.
• The Honest Company, Inc. HNST fell 26.3% to $4.45 after the company reported worse-than-expected Q4 EPS and sales results.
• Enfusion, Inc. ENFN dropped 19.8% to $12.20 after the company reported Q4 earnings results and issued Q1 and FY22 guidance.
• CuriosityStream Inc. CURI fell 17.7% to $3.01 after the company reported Q4 earnings results and issued H1 guidance.
• Orion Office REIT Inc. ONL fell 15.7% to $15.16 after the company reported Q4 earnings results.
• Mullen Automotive, Inc. MULN dropped 15.4% to $2.5395.
• Dave Inc. DAVE fell 14.7% to $7.18.
• OneConnect Financial Technology Co., Ltd. OCFT declined 14.6% to $1.8100.
• Asana, Inc. ASAN fell 13.6% to $36.91. Asana recently filed for mixed shelf offering.
• Indonesia Energy Corporation Limited INDO fell 12.3% to $22.22.
• Huntsman Corporation HUN dropped 12% to $35.61.
• Rezolute, Inc. RZLT declined 10.8% to $3.5650.
• CynergisTek, Inc. CTEK fell 9.8% to $1.35 after the company said FY21 sales results were lower than the previous year.
• NIO Inc. NIO fell 9.8% to $19.83. Nio reported better-than-expected results for its fourth quarter. The company's first-quarter guidance suggested sequentially flat to slightly higher deliveries and below-consensus revenues.
• Co-Diagnostics, Inc. CODX fell 9.7% to $5.88 after the company reported FY21 earnings results and issued Q1 EPS guidance above estimates.
• Bilibili Inc. BILI dropped 9.5% to $27.43.
• DiDi Global Inc. DIDI fell 9.3% to $3.4450.
• Canaan Inc. CAN fell 8.8% to $5.89.
• SmartRent, Inc. SMRT fell 6.7% to $5.88 as the company reported a wider-than-expected loss for its fourth quarter and issued weak sales guidance. The company also said it acquired SightPlan Inc. on March 22 for $135 million.
• Cyren Ltd. CYRN fell 5% to $7.18 after the company reported worse-than-expected Q4 sales results.